Wordt geladen...
p53 at the crossroads of MPN treatment
In this issue of Blood, Lu et al describe the cooperation between an orally bioavailable mouse double minute 2 (MDM2) antagonist (RG7112) and the pegylated interferon α (Peg-IFNα 2a) to target JAK2V617F hematopoietic progenitors and stem cells. Their work provides a rationale for the treatment of pa...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4118478/ https://ncbi.nlm.nih.gov/pubmed/25082860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-579623 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|